• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过含有CD45胞质结构域的嵌合蛋白进行信号拯救。

Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45.

作者信息

Hovis R R, Donovan J A, Musci M A, Motto D G, Goldman F D, Ross S E, Koretzky G A

机构信息

Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.

出版信息

Science. 1993 Apr 23;260(5107):544-6. doi: 10.1126/science.8475387.

DOI:10.1126/science.8475387
PMID:8475387
Abstract

Surface expression of the CD45 tyrosine phosphatase is essential for the T cell antigen receptor (TCR) to couple optimally with its second messenger pathways. CD45 may be required to dephosphorylate a TCR-activated protein tyrosine kinase, which then transduces an activation signal from the TCR. A chimeric molecule that contained extracellular and transmembrane sequences from an allele of a major histocompatibility class I molecule and cytoplasmic sequences of CD45 restored TCR signaling in a CD45-deficient mutant T cell line. Thus, expression of the complex extracellular domain of CD45 is not required for the TCR to couple to its signaling machinery.

摘要

CD45 酪氨酸磷酸酶的表面表达对于 T 细胞抗原受体(TCR)与其二信使途径的最佳偶联至关重要。可能需要 CD45 使 TCR 激活的蛋白酪氨酸激酶去磷酸化,然后该激酶从 TCR 转导激活信号。一种嵌合分子,其包含来自主要组织相容性复合体 I 类分子一个等位基因的细胞外和跨膜序列以及 CD45 的细胞质序列,可在 CD45 缺陷的突变 T 细胞系中恢复 TCR 信号传导。因此,TCR 与其信号传导机制偶联并不需要 CD45 复杂细胞外结构域的表达。

相似文献

1
Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45.通过含有CD45胞质结构域的嵌合蛋白进行信号拯救。
Science. 1993 Apr 23;260(5107):544-6. doi: 10.1126/science.8475387.
2
Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains.缺乏跨膜和胞外结构域的CD45对TCR信号的调节
Science. 1993 Apr 23;260(5107):541-4. doi: 10.1126/science.8475386.
3
Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase.配体介导的嵌合跨膜受体酪氨酸磷酸酶的负调控
Cell. 1993 May 7;73(3):541-54. doi: 10.1016/0092-8674(93)90141-c.
4
The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation.TCR信号传导和调节需要CD45膜近端磷酸酶结构域的催化活性。
EMBO J. 1994 Sep 1;13(17):4002-10. doi: 10.1002/j.1460-2075.1994.tb06716.x.
5
Restoration of CD2-mediated signaling by a chimeric membrane protein including the cytoplasmic sequence of CD45.通过包含CD45胞质序列的嵌合膜蛋白恢复CD2介导的信号传导。
Hum Immunol. 1994 Jun;40(2):123-30. doi: 10.1016/0198-8859(94)90056-6.
6
Surface expression of a heterologous phosphatase complements CD45 deficiency in a T cell clone.异源磷酸酶的表面表达可弥补T细胞克隆中CD45的缺陷。
J Exp Med. 1994 Oct 1;180(4):1359-66. doi: 10.1084/jem.180.4.1359.
7
The CD45 tyrosine phosphatase regulates specific pools of antigen receptor-associated p59fyn and CD4-associated p56lck tyrosine in human T-cells.CD45 酪氨酸磷酸酶调节人 T 细胞中特定池的抗原受体相关 p59fyn 和 CD4 相关 p56lck 酪氨酸。
EMBO J. 1994 Apr 15;13(8):1920-9. doi: 10.1002/j.1460-2075.1994.tb06461.x.
8
An activated epidermal growth factor receptor/Lck chimera restores early T cell receptor-mediated calcium response in a CD45-deficient T cell line.一种活化的表皮生长因子受体/Lck嵌合体可恢复CD45缺陷型T细胞系中早期T细胞受体介导的钙反应。
J Biol Chem. 1996 Jul 26;271(30):17896-902. doi: 10.1074/jbc.271.30.17896.
9
The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation.CD45的胞外结构域控制与CD4-T细胞受体复合物的结合以及对抗原特异性刺激的反应。
J Exp Med. 1996 Jan 1;183(1):249-59. doi: 10.1084/jem.183.1.249.
10
Restoration of T cell receptor-mediated signal transduction by transfection of CD45 cDNA into a CD45-deficient variant of the Jurkat T cell line.通过将CD45互补DNA转染到Jurkat T细胞系的CD45缺陷变体中来恢复T细胞受体介导的信号转导。
J Immunol. 1992 Aug 15;149(4):1138-42.

引用本文的文献

1
CD45 limits early Natural Killer cell development.CD45 限制早期自然杀伤细胞的发育。
Immunol Cell Biol. 2024 Jan;102(1):58-70. doi: 10.1111/imcb.12701. Epub 2023 Oct 19.
2
The interplay between membrane topology and mechanical forces in regulating T cell receptor activity.膜拓扑结构与机械力在调节 T 细胞受体活性中的相互作用。
Commun Biol. 2022 Jan 11;5(1):40. doi: 10.1038/s42003-021-02995-1.
3
BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.BTN3A1 通过协调 αβ 和 γδ T 细胞来控制抗肿瘤反应。
Science. 2020 Aug 21;369(6506):942-949. doi: 10.1126/science.aay2767.
4
High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation.高亲和配体可触发 T 细胞受体信号而不发生 CD45 分离。
Front Immunol. 2018 Apr 9;9:713. doi: 10.3389/fimmu.2018.00713. eCollection 2018.
5
Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.CD45的表位特异性交联可下调膜相关酪氨酸磷酸酶活性,并触发人活化T细胞中的早期信号事件。
Immunology. 2004 Dec;113(4):441-52. doi: 10.1111/j.1365-2567.2004.01986.x.
6
Integrin-mediated tyrosine phosphorylation of Shc in T cells is regulated by protein kinase C-dependent phosphorylations of Lck.整合素介导的T细胞中Shc的酪氨酸磷酸化受Lck的蛋白激酶C依赖性磷酸化调节。
Mol Biol Cell. 2003 Feb;14(2):349-60. doi: 10.1091/mbc.e02-07-0382.
7
Disruption of lymphocyte function and signaling in CD45-associated protein-null mice.CD45相关蛋白缺失小鼠中淋巴细胞功能和信号传导的破坏。
J Exp Med. 1998 Jun 1;187(11):1863-70. doi: 10.1084/jem.187.11.1863.
8
CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.CD45和RPTPα在T淋巴细胞中表现出不同的蛋白酪氨酸磷酸酶活性。
Biochem J. 1997 Nov 1;327 ( Pt 3)(Pt 3):867-76. doi: 10.1042/bj3270867.
9
Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.蛋白酪氨酸磷酸酶CD45和SHP-1对细胞信号传导的调控。
Immunol Res. 1997 Feb;16(1):101-13. doi: 10.1007/BF02786326.
10
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation.CD45基因敲除的转基因小鼠揭示了CD45在早期胸腺细胞发育、CD4+CD8+胸腺细胞选择以及B细胞成熟过程中的正向调节作用。
J Exp Med. 1996 Apr 1;183(4):1707-18. doi: 10.1084/jem.183.4.1707.